Published in Surg Today on May 31, 2008
Hepatic angiomyolipoma: a series of six cases with emphasis on pathological-radiological correlations and unusual variants diagnosed by core needle biopsy. Int J Clin Exp Pathol (2012) 1.21
Hepatic angiomyolipoma with minimal fat, mimicking hepatocellular carcinoma. Clin Mol Hepatol (2012) 0.89
Ruptured hepatic epithelioid angiomyolipoma: a case report and literature review. Case Rep Oncol (2014) 0.88
Angiomyolipoma of the colon: report of a case. Surg Today (2009) 0.82
Multi-slice computed tomography manifestations of hepatic epithelioid angiomyolipoma. World J Gastroenterol (2014) 0.80
A hepatic lipoma mimicking angiomyolipoma of the liver: report of a case. Surg Today (2009) 0.78
Tuberous sclerosis associated with multiple hepatic lipomatous tumours. Images Paediatr Cardiol (2017) 0.75
Myomatous hepatic angiomyolipoma: imaging findings in 14 cases with radiological-pathological correlation and review of the literature. Br J Radiol (2014) 0.75
Hepatic falciform ligament clear cell myomelanocytic tumor: A case report and a comprehensive review of the literature on perivascular epithelioid cell tumors. BMC Cancer (2015) 0.75
Three trocars laparoscopic resection of angiomyolipoma of the liver. Int J Hepatol (2011) 0.75
Anastomosing haemangioma of liver: A case report. Mol Clin Oncol (2017) 0.75
Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology (2000) 3.24
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Diagnosis and treatment of hepatic angiomyolipoma in 26 cases. World J Gastroenterol (2003) 1.71
Spontaneous rupture of a hepatic angiomyolipoma: CT findings and literature review. Eur Radiol (1997) 1.34
Angiomyolipomas of the liver. Am J Surg Pathol (1984) 1.28
Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol (2002) 1.27
Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma. Eur Radiol (2001) 1.22
Hepatic angiomyolipoma: various appearances on two-phase contrast scanning of spiral CT. Eur J Radiol (2002) 1.12
Epithelioid angiomyolipoma of the liver: case report and review of the literature. APMIS (2004) 1.11
[Malignant-like angiomyolipoma of the liver: report of one case and review of the literature]. Ann Chir (2005) 1.04
Invasive growth of hepatic angiomyolipoma; a hitherto unreported ominous histological feature. Histopathology (2006) 1.02
Hepatic angiomyolipoma. A report of four cases with immunohistochemical and DNA-flow cytometric studies. Arch Pathol Lab Med (1996) 1.01
Immunohistochemical study of hepatic angiomyolipoma. Pathol Int (1996) 0.98
Hepatic angiomyolipoma with trace amounts of fat: a case report and literature review. J Clin Pathol (2006) 0.97
Pathological and molecular analysis of sporadic hepatic angiomyolipoma. Hum Pathol (2006) 0.97
Case report of a hepatic angiomyolipoma. Tumori (2004) 0.88
Hepatic angiomyolipoma. Abdom Imaging (1995) 0.87
Hepatic angiomyolipoma and hepatic stellate cells share a similar gene expression profile. Hum Pathol (2005) 0.87
Hepatic angiomyolipoma: radiologic and histopathologic correlation. Abdom Imaging (2002) 0.86
Multifocal angiomyolipoma affecting the liver and lung without tuberous sclerosis. J Clin Pathol (2004) 0.84
Immunohistochemical study of hepatic angiomyolipoma. Hepatogastroenterology (2005) 0.81
Preoperative diagnosis of renal angiomyolipoma with fine needle aspiration cytology: a report of 3 cases. Acta Cytol (2006) 0.80
Aggressive hepatic angiomyolipoma in a child. Pediatr Hematol Oncol (2005) 0.78
Pulmonary angiomyolipoma. Ann Thorac Surg (2006) 0.77
[Hepatic and renal angiomyolipoma]. Chirurgie (1995) 0.75
Multiple hepatic angiomyolipomas with a solitary omental angiomyolipoma. J Med Invest (2005) 0.75
Spontaneous rupture of renal angiomyolipoma: value of multidetector CT angiography for interventional therapy. Emerg Radiol (2005) 0.75
[Hepatic angiomyolipoma. Magnetic resonance imaging and imaging by CT-xray]. J Radiol (1995) 0.75
Traumatic rupture of renal angiomyolipoma managed with angioembolization followed by elective surgery: a report of two cases. J Trauma (2005) 0.75
The NIH Human Microbiome Project. Genome Res (2009) 24.61
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci U S A (2007) 11.85
Genome-wide association studies of 14 agronomic traits in rice landraces. Nat Genet (2010) 8.75
MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med (2009) 6.13
High-throughput genotyping by whole-genome resequencing. Genome Res (2009) 5.74
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology (2008) 5.53
Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med (2003) 5.45
Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol (2004) 5.29
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol (2007) 5.28
Physical activity and weight gain prevention. JAMA (2010) 5.27
Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling. Sci Transl Med (2011) 4.91
Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology (2008) 4.50
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell (2006) 4.33
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol (2012) 4.21
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res (2008) 4.17
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology (2009) 3.92
Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys (2010) 3.87
Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol (2011) 3.80
Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. J Clin Oncol (2013) 3.76
Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas. Cancer Discov (2013) 3.64
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet (2011) 3.41
Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res (2009) 3.39
Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet (2012) 3.14
MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res (2011) 3.03
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol (2008) 2.92
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1. Proc Natl Acad Sci U S A (2012) 2.89
HIV prevalence in China: integration of surveillance data and a systematic review. Lancet Infect Dis (2013) 2.82
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol (2010) 2.65
A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res (2010) 2.59
A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol (2003) 2.50
The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol (2002) 2.47
Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol (2011) 2.47
Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. J Clin Oncol (2013) 2.44
Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study. Lancet (2012) 2.41
Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood (2002) 2.41
Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ Res (2003) 2.27
HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China. Clin Infect Dis (2013) 2.24
Telemedical retinopathy of prematurity diagnosis: accuracy, reliability, and image quality. Arch Ophthalmol (2007) 2.22
Sperm, but not oocyte, DNA methylome is inherited by zebrafish early embryos. Cell (2013) 2.16
Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity (2012) 2.16
Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol (2003) 2.07
The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol (2002) 2.03
BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature (2012) 2.00
MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Hepatology (2014) 1.97
Estimating the number of people living with HIV/AIDS in China: 2003-09. Int J Epidemiol (2010) 1.96
Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol (2006) 1.95
Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care (2013) 1.95
Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J Leukoc Biol (2007) 1.94
Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program. Arthritis Rheumatol (2014) 1.91
The genomics of selection in dogs and the parallel evolution between dogs and humans. Nat Commun (2013) 1.86
The development of HIV/AIDS surveillance in China. AIDS (2007) 1.86
Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol (2007) 1.86
Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol (2004) 1.86
Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res (2008) 1.85
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology (2013) 1.84
A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer J (2004) 1.84
Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol (2004) 1.83
PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. Genes Dev (2010) 1.82
Intelliject's novel epinephrine autoinjector: sharps injury prevention validation and comparable analysis with EpiPen and Twinject. Ann Allergy Asthma Immunol (2010) 1.81
Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy (2011) 1.81
Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics (2011) 1.81
Pentamidine-induced long QT syndrome and block of hERG trafficking. J Pharmacol Exp Ther (2004) 1.76
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol (2004) 1.75
Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin Cancer Res (2007) 1.73
Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Clin Cancer Res (2010) 1.72